model: gpt-4-1106-preview
prompt: Write a paragraph of text in the style of a biomedical research article. Include the following protein complex name: PRC2. Use this name exactly as provided, avoiding any synonyms, aliases, abbreviated or expanded forms. Also avoid including any other names referring to a gene, protein, protein complex, protein part or component, or any other molecular entity containing amino acid residues. The text can include mentions of other biomedical entity types, such as chemical, organism, and disease names.
output: In the exploration of epigenetic mechanisms governing cellular differentiation and oncogenesis, significant attention has been directed toward Polycomb Repressive Complex 2 (PRC2). This multiprotein complex is pivotal in the methylation of histone H3 at lysine 27 (H3K27me3), a post-translational modification associated with transcriptional repression. Empirical studies employing mouse models have provided evidence that dysregulation of PRC2 activity is intricately linked to the pathogenesis of certain cancers, such as malignant gliomas. Recent experiments utilizing dual transcriptome and methylome sequencing have illuminated the complex interplay between PRC2-mediated methylation and the remodeling of chromatin architecture. Investigations involving specific inhibitors have revealed that PRC2 exerts a profound influence on gene silencing across various pathways integral to cell cycle progression and apoptosis. The therapeutic potential of modulating PRC2 activity underscores the necessity of understanding its structure-function relationships, particularly within the dynamic environments of stem cells and cancer cells. Further, investigation into the interaction of PRC2 with small-molecule effectors has begun to unveil novel avenues for pharmacological intervention, offering hope for targeted epigenetic therapies.
